Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP). / Safrygin, Alexander; Zhmurov, Petr; Dar’in, Dmitry; Silonov, Sergey; Kasatkina, Mariia; Zonis, Yulia; Gureev, Maxim; Krasavin, Mikhail.
In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, No. 1, 2021, p. 1916-1921.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP)
AU - Safrygin, Alexander
AU - Zhmurov, Petr
AU - Dar’in, Dmitry
AU - Silonov, Sergey
AU - Kasatkina, Mariia
AU - Zonis, Yulia
AU - Gureev, Maxim
AU - Krasavin, Mikhail
N1 - Publisher Copyright: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - An earlier described three-component variant of the Castagnoli-Cushman reaction employing homophthalic anhydrides, carbonyl compound and ammonium acetate was applied towards the preparation of 1-oxo-3,4-dihydroisoquinoline-4-carboxamides with variable substituent in position 3. These compounds displayed inhibitory activity towards poly(ADP-ribose) polymerase (PARP), a clinically validated cancer target. The most potent compound (PARP1/2 IC50 = 22/4.0 nM) displayed the highest selectivity towards PARP2 in the series (selectivity index = 5.5), more advantageous ADME prameters compared to the clinically used PARP inhibitor Olaparib.
AB - An earlier described three-component variant of the Castagnoli-Cushman reaction employing homophthalic anhydrides, carbonyl compound and ammonium acetate was applied towards the preparation of 1-oxo-3,4-dihydroisoquinoline-4-carboxamides with variable substituent in position 3. These compounds displayed inhibitory activity towards poly(ADP-ribose) polymerase (PARP), a clinically validated cancer target. The most potent compound (PARP1/2 IC50 = 22/4.0 nM) displayed the highest selectivity towards PARP2 in the series (selectivity index = 5.5), more advantageous ADME prameters compared to the clinically used PARP inhibitor Olaparib.
KW - 1-oxo-3,4-dihydroisoquinoline-4-carboxamides
KW - Castagnoli-Cushman reaction
KW - druglikeness
KW - NAD mimetics
KW - PARP1/2 selectivity
KW - poly(ADP-ribose) polymerase
KW - PARP1
KW - 2 selectivity
KW - NAD(+) mimetics
KW - DISCOVERY
KW - 4-dihydroisoquinoline-4-carboxamides
KW - IN-VITRO
KW - 1-oxo-3
UR - http://www.scopus.com/inward/record.url?scp=85113996517&partnerID=8YFLogxK
U2 - 10.1080/14756366.2021.1969386
DO - 10.1080/14756366.2021.1969386
M3 - Article
AN - SCOPUS:85113996517
VL - 36
SP - 1916
EP - 1921
JO - Journal of Enzyme Inhibition and Medicinal Chemistry
JF - Journal of Enzyme Inhibition and Medicinal Chemistry
SN - 1475-6366
IS - 1
ER -
ID: 85382835